Left ventricular assist devices as destination therapy for end-stage heart failure

Left ventricular assist devices as destination therapy for end-stage heart failure

Because of progressive diabetes with end organ damage (retinopathy) and his advanced age, he is not considered an ideal transplant candidate. [...]the REMATCH trial was conducted with the first generation HeartMate device; subsequent advances in VAD technology have incorporated changes specifically...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American heart journal 2004-08, Vol.148 (2), p.252-253
Hauptverfasser: Yager, Jonathan E.E., Felker, G.Michael
Format: Artikel
Sprache:eng
Schlagworte:
Aged
Biological and medical sciences
Candidates
Cardiology. Vascular system
Drug therapy
Heart
Heart attacks
Heart failure
Heart Failure - therapy
Heart failure, cardiogenic pulmonary edema, cardiac enlargement
Heart-Assist Devices
Humans
Male
Medical sciences
Mortality
Older people
Patients
Quality of life
Survival Analysis
Transplants & implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Because of progressive diabetes with end organ damage (retinopathy) and his advanced age, he is not considered an ideal transplant candidate. [...]the REMATCH trial was conducted with the first generation HeartMate device; subsequent advances in VAD technology have incorporated changes specifically designed to address these issues.
ISSN:0002-8703
1097-6744
DOI:10.1016/j.ahj.2004.06.013